Navigation Links
VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
Date:4/20/2012

ts the view that VeriStrat may be useful in identifying lung cancer patients that could benefit from the combination of bevacizumab and erlotinib, which is regarded as less toxic than traditional chemotherapy."

About VeriStrat:  VeriStrat is a serum proteomic test currently available for patients with advanced NSCLC.  The test identifies patients who are likely to have good or poor outcomes after treatment with epidermal growth factor receptor inhibitors (EGFRIs).  Samples are processed in Biodesix' CLIA certified laboratory and results are typically reported within 72 hours of sample shipment.  VeriStrat has been validated in clinical studies with over 1500 patients.  For more information on VeriStrat or to order VeriStrat, visit www.VeriStratSupport.com or call the VeriStrat Support Hotline at 1-866-432-5930.

About Biodesix:  Biodesix is a personalized medicine company focused on the development of diagnostic products that inform treatment decisions and improve patient care.  The Company's goal is to give physicians more information about the patient and their disease; understanding the clinically meaningful information contained within each patient's molecular profile leads to better care and better outcomes. The Company's unique approach is based on ProTS®, proprietary technology which exploits the power of mass spectrometry and enables the discovery of specific molecular profiles. Biodesix collaborates with clinical investigators to address critical clinical questions, and partners with biotechnology and pharmaceutical companies to develop diagnostics to select patients most likely to benefit from novel therapies. For more information about Biodesix, please visit www.Biodesix.com.

This press release contains statements that are hereby identified as "forward-looking statements" for purposes of the safe
'/>"/>

SOURCE Biodesix
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodesix Announces New VeriStrat® Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
2. VeriStrat® Results Correlate with Survival Outcomes in Kidney Cancer Patients
3. VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Cepheid Reports 2012 First Quarter Results
6. Amgen Announces Webcast of 2012 First Quarter Financial Results
7. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
8. Masimo to Report First Quarter 2012 Financial Results after Market Close on May 2
9. Solta Medical to Report First Quarter 2012 Results Release and Host Conference Call on May 1
10. Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012
11. Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Northstar Global Business Services, Inc., Symbol ... hard work from many talented specialists, the company ... package design.  The new formulation for Snorenz original ... product due to overwhelming evidence of increased efficacy ... will also include these vitamins, as well as ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kentucky blocked the sale of ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Missouri. The ... (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 19,030 boxes of medicine ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Tissues at Well-Tolerated ... Doses, ... data from a phase 1 dose-escalation trial of XL765, a,novel small molecule ... proliferation, survival, and,resistance to chemotherapy and radiotherapy. The trial is being carried ...
... III clinical trial --, CHICAGO, May 31 ... the presentation of updated results from,a 482 patient, ... dexamethasone (VcD) to vincristine, adriamycin and,dexamethasone (VAD). Results ... in the VcD arm as induction therapy and ...
Cached Medicine Technology:Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 3Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 4Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6
(Date:8/21/2014)... Recently, Van Uden Center has noticed ... is on the rise and much of that ... Fiscal Times, young people are becoming more accepting ... The Fiscal Times published an article on July ... medicine. The article can be found at ...
(Date:8/21/2014)... Line: Patients with advanced laryngeal cancer appear to ... surgery than nonsurgical chemoradiation. , Author: Uchechukwu C. ... Medicine at Mount Sinai, New York, and colleagues. ... laryngeal cancer are diagnosed each year and squamous ... these tumors. Prior to 1991, total surgical removal ...
(Date:8/21/2014)... the environmental source of fungal infections that have been ... literally grows on trees. , The discovery is based ... spent the summer gathering soil and tree samples from ... the fungus named Cryptococcus gattii (CRIP-to-cock-us ... number of species including C. gattii , causes ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Not only is ... can save them hundreds of health-care dollars a year, a ... a professor of public health sciences at Wake Forest Baptist ... overweight and obese type 2 diabetes patients. ... randomly assigned to either an intensive "lifestyle change program" focused ...
(Date:8/21/2014)... Honolulu (PRWEB) August 21, 2014 ... its 10th anniversary and a national voice in ... leaders in health disparities during the 112th National ... , Distinguished honorees included: , John Ruffin, Ph.D, ... Health and Health Disparities, whose life-long career and ...
Breaking Medicine News(10 mins):Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2
... -- The recently formed Mayo Clinic Center for ... the formation of the Social Media Health Network, ... promote health, improve health care and fight disease. ... platforms for sharing training materials and resources, this ...
... Against Cancer, are pioneering the use of a common curry ... the University Department of Cancer Studies and Molecular Medicine is ... undergoing surgery. The aim is use tissue from the ... extract of the commonly used root turmeric. ...
... Ill. Using incidental findings from routine diagnostic CT, radiologists ... for cardiovascular disease, according to a new study appearing online ... "The results of this study show that radiologists can predict ... the aortic wall on CT, along with minimal patient information, ...
... on how African American patients with asthma respond to ... Researchers found that improved lung function in patients after ... baseline breathing function measures, not genetic ancestry. The study ... & Clinical Immunology , http://www.aaaai.org/media/jaci/ Advances ...
... Ellin Holohan HealthDay Reporter , MONDAY, Sept. 27 ... predict stroke patients, risk of dying in the hospital and ... new Canadian study. Hospitals also can use the ... study author Dr. Eric Smith, assistant professor of neurology at ...
... American Association of Cardiovascular and Pulmonary Rehabilitation will ... Angeles Biomedical Research Institute (LA BioMed) principal investigator, ... meeting in Milwaukee. Dr. Casaburi, who holds ... Rehabilitative Sciences at LA BioMed and leads its ...
Cached Medicine News:Health News:Mayo Clinic Center for Social Media launches global Social Media Health Network 2Health News:Mayo Clinic Center for Social Media launches global Social Media Health Network 3Health News:Curry cooking ingredient could provide recipe for fight against cancer 2Health News:Researchers use CT to predict heart disease 2Health News:No link between genetic ancestry, asthma response in African-Americans 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 2Health News:New Tool Helps Predict Stroke Patient's Risk of Death in Hospital: Study 3Health News:LA BioMed researcher to receive prestigious honor 2
... Viscoelastic System is designed to give two ... can be used differently and sequentially to ... The choice of the viscoelastic is based ... of each to facilitate performance of the ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... and the FF 450plus Fundus Camera are ... of accuracy and security that can't be ... Without this level of integrated synergy, calibration ... VISUPAC system pixel for pixel, the FF ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
Medicine Products: